PAX7
Paired box protein Pax-7
Also known as: Hup1, PAX7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P23759
- Gene
- PAX7
- Ensembl
- ENSG00000009709
- Chromosome
- 1
- Canonical length
- 505 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The specific function of the paired box 7 gene is unknown but speculated to involve tumor suppression since fusion of this gene with a forkhead domain family member has been associated with alveolar rhabdomyosarcoma. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]
Canonical amino-acid sequenceUniProt
505 residues, UniProt reviewed canonical sequence.
>P23759|PAX7
1 MAALPGTVPR MMRPAPGQNY PRTGFPLEVS TPLGQGRVNQ LGGVFINGRP LPNHIRHKIV
61 EMAHHGIRPC VISRQLRVSH GCVSKILCRY QETGSIRPGA IGGSKPRQVA TPDVEKKIEE
121 YKRENPGMFS WEIRDRLLKD GHCDRSTVPS GLVSSISRVL RIKFGKKEEE DEADKKEDDG
181 EKKAKHSIDG ILGDKGNRLD EGSDVESEPD LPLKRKQRRS RTTFTAEQLE ELEKAFERTH
241 YPDIYTREEL AQRTKLTEAR VQVWFSNRRA RWRKQAGANQ LAAFNHLLPG GFPPTGMPTL
301 PPYQLPDSTY PTTTISQDGG STVHRPQPLP PSTMHQGGLA AAAAAADTSS AYGARHSFSS
361 YSDSFMNPAA PSNHMNPVSN GLSPQVMSIL GNPSAVPPQP QADFSISPLH GGLDSATSIS
421 ASCSQRADSI KPGDSLPTSQ AYCPPTYSTT GYSVDPVAGY QYGQYGQTAV DYLAKNVSLS
481 TQRRMKLGEH SAVLGLLPVE TGQAYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAX7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 5.3 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 5.3 nTPM
- tongue: 4.1 nTPM
- cerebral cortex: 1 nTPM
- spinal cord: 0.4 nTPM
- amygdala: 0.2 nTPM
- esophagus: 0.2 nTPM
Single-cell type
- myosatellite cells: 928 nCPM
- pituitary stem cells: 24 nCPM
- tuft cells: 12 nCPM
- fibro-adipogenic progenitors: 5 nCPM
- respiratory basal cells: 4 nCPM
- brain inhibitory neurons: 3.8 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- midbrain: 10 nTPM
- medulla oblongata: 7.1 nTPM
- spinal cord: 5.8 nTPM
- pons: 5.6 nTPM
- cerebral cortex: 3.3 nTPM
- cerebellum: 3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PAX7.
Disease | AllUniProt
Conditions PAX7 is implicated in, by any mechanism.
- Rhabdomyosarcoma 2 (RMS2) MIM:268220
- Congenital myopathy 19 (CMYO19) MIM:618578
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 119 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Myopathy, congenital, progressive, with scoliosis
- Alveolar rhabdomyosarcoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 0.8
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anatomical structure morphogenesis
- cartilage development
- chromatin remodeling
- dorsal/ventral neural tube patterning
- embryonic skeletal system development
- muscle tissue morphogenesis
- negative regulation of apoptotic process
- nervous system development
- neuron fate commitment
- positive regulation of myoblast proliferation
- positive regulation of transcription by RNA polymerase II
- regulation of cell fate commitment
- regulation of chromatin organization
- regulation of transcription by RNA polymerase II
- skeletal muscle satellite cell differentiation
- skeletal muscle tissue regeneration
- spinal cord association neuron differentiation
- transcription by RNA polymerase II
- skeletal muscle satellite cell commitment
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PAX7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAX7 as an antibody target. Whether an autoantibody or antibody against PAX7 could matter depends on whether native PAX7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAX7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PAX7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...